A stroke drug scrapped by Biogen has helped more people to walk independently 12 months after a large hemispheric infarction (LHI), the most serious form of ischaemic stroke, in a Phase III trial.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,